Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.23.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies  
Schedule of dilutive securities excluded from the computation of diluted weighted average shares

As of June 30, 

    

2023

    

2022

Common stock purchase options

314,672

 

410,639

Restricted stock units

19,823

 

Common stock purchase warrants

5,794,071

 

9,000

6,128,566

 

419,639

Schedule of warrant liabilities were measured at fair value on a recurring basis

    

Fair Value Measurements 

as of June 30, 2023

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Liabilities

 

  

 

  

 

  

 

  

Warrant liabilities

$

 

 

4,239,496

$

4,239,496

Schedule of assumptions were used in determining the fair value of the warrant liabilities

    

As of June 30, 2023

Remaining contractual term (years)

 

1.5 - 5.5

Common stock price volatility

 

86.1% - 102.8%

Risk-free interest rate

 

3.94% - 5.02%

Expected dividend yield

 

Schedule of change in fair value of the warrant liabilities

Warrant

Liabilities

Balance as of March 31, 2023

$

Fair value of warrants issued

5,669,847

Change in fair value

 

(1,430,351)

Balance as of June 30, 2023

$

4,239,496